Mossakowski Medical Research Institute

What Mossakowski Medical Research Institute does

Mossakowski Medical Research Institute (Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego PAN, IMDiK PAN) is a Polish Academy of Sciences biomedical research institute established in 1967 and headquartered in Warsaw's Ochota district. The institute integrates basic research, preclinical studies, and clinical translation across 29 research units — 12 laboratories, 10 independent units, 3 clinical-research teams, and 3 research platforms — supported by 150 scientific staff including 29 full professors and 21 habilitated doctors. Research priorities span civilizational diseases (cancer, neurodegeneration, diabetes, obesity, osteoporosis), rare diseases, healthy aging, and regenerative medicine, leveraging CRISPR, iPSCs, organoids, animal models (mice, rats, Mongolian gerbils, zebrafish), super-resolution and electron microscopy, and small-animal MRI/MRS. A ~3,000 m² SPF laboratory animal facility and four commercial service laboratories (microscopy, MRI, toxicology, animal breeding) underpin both in-house science and external service delivery.

The institute is funded through a mix of Polish Academy of Sciences core funding, competitive grants from NCN, NCBR, ABM, EU Framework Programmes, and NAWA, alongside fee-for-service preclinical research, imaging, toxicology, and animal-breeding contracts with biotech and pharmaceutical clients. It awards the IMDiK Quality Mark (Znak Jakości) for tested medical devices, pharmaceuticals, cosmetics, dietary supplements, and diagnostic methods. IMDiK PAN holds the Polish Ministry's A+ category in medical sciences, KNOW status (2012), and the European Commission's HR Excellence in Research badge (2017, renewed 2023), and participates in BioImaging Poland, Biocentrum Ochota, CEPT, and Euro-BioImaging consortia. The institute publishes roughly 200 JCR-indexed papers per year and co-publishes Folia Neuropathologica, and was ranked highest among Polish institutes in the SCImago 2025 ranking. Leadership comprises Director Prof. Leonora Buczańska, with deputies for scientific affairs, finance, and development and cooperation.

Name

Mossakowski Medical Research Institute

Legal name

Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego Polskiej Akademii Nauk

Website

https://imdik.pan.pl

Company type

Private

Founded year

1967

Operating status

Operating

Headcount range

101–250 employees

Short description

IMDiK PAN is a Polish Academy of Sciences biomedical research institute in Warsaw conducting basic, preclinical, and clinical research in cancer, neurodegeneration, and regenerative medicine for academic, biotech, and pharmaceutical clients.

Ownership category

akta.pro rank

Product category

Preclinical Research Services

NAICS

Research and Development in Biotechnology (except Nanobiotechnology) (541714), Scientific Research and Development Services (5417)

SIC

Services-Commercial Physical & Biological Research (8731), Services-Medical Laboratories (8071)

akta.pro industry

PRIMARYEDAHAGAI

Biomedical Sciences & Medical Research Institutes (University-Based)

Education/Higher Education (Colleges & Universities)/Medical & Health Sciences Universities

SECONDARYHLAGADAH

Cell-Based & Potency Assays (Bioassays)

Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Laboratory Testing & Analytical Services

SECONDARYHLAGAEAG

Bioanalytical & PK/PD Sample Analysis (Trial Support)

Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Central Labs & Clinical Diagnostics Services (Trial Support)

SECONDARYHLACAMAH

Quality Management & Regulatory Compliance (CLIA/CAP/ISO) for Labs

Healthcare & Life Sciences/Digital Health & Health IT/Laboratory Information Systems (LIS/LIMS) & Pathology Informatics

Keywords

• Preclinical research services
• Biomedical research institute
• Animal model studies
• Microscopy imaging services
• Pharmacological testing services

Headquarters

HQ city

Ochota

HQ country

Poland

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Infrastructure, Supply Chain

Revenue model

1. Government Funding (Polish Academy of Sciences): Core institutional funding from the Polish Academy of Sciences (PAN) providing operational base funding for research activities
2. Research Grants: Funding from Polish national agencies (NCN - National Science Centre, NCBR - National Centre for Research and Development, ABM - Medical Research Agency) and international sources (EU Framework Programmes, NAWA)
3. Commercial Research Services: Fee-for-service preclinical research services, microscopy imaging, MRI imaging, toxicology testing, and animal breeding services for external biotech and pharmaceutical clients
4. Quality Mark Certification: The Quality Mark awarded to products/methods tested at the institute for medical devices, pharmaceutical products, cosmetics, dietary supplements, and diagnostic methods

Go-to-market motion3 records

Distribution channels4 records

Marketing channels5 records

Core offering

Mossakowski Medical Research Institute (IMDiK PAN) is a state-funded biomedical research institute of the Polish Academy of Sciences that conducts integrated basic, preclinical, and clinical-translational research in oncology, neurology, regenerative medicine, and rare/civilizational diseases. It also offers fee-based preclinical research services through specialized Environmental Laboratories, including advanced microscopy, MRI imaging, toxicology testing, animal breeding, and a quality mark certification for biomedical products.

Product overview

Mossakowski Medical Research Institute (IMDiK PAN) is a biomedical research institution that offers a comprehensive portfolio of research services through its Environmental Laboratories within the Preclinical Research and Services Zone. The core service offerings include six main categories: (1) Microscopic Imaging with Super-Resolution Techniques and Laser Microdissection through the Environmental Laboratory of Laser Microscopic Techniques (LLTM), part of Euro-BioImaging infrastructure; (2) Small Animal Magnetic Resonance Imaging (MRI/MRS) for preclinical studies; (3) Cytotoxicity Assessment on Cell Cultures through pharmacological and toxicological research services; (4) Laboratory Animal Breeding and Housing for genetically modified rodents under SPF conditions; (5) Electron Microscopy Imaging; and (6) the IMDiK PAN Quality Mark certification service for products and diagnostic methods. The institute also publishes the journal Folia Neuropathologica in partnership with the Association of Polish Neuropathologists.

Differentiator

Problem solved

Functional benefit

Products and services

• Microscopic Imaging with Super-Resolution Techniques and Laser Microdissection Advanced microscopic imaging, super-resolution techniques, and laser microdissection services provided by the Environmental Laboratory of Laser Microscopic Techniques (LLTM). Part of the Euro-BioImaging pan-European infrastructure and Bio-Imaging Poland (BIPol) consortium; serves external researchers and biotech clients.
• Small Animal Magnetic Resonance Imaging (MRI/MRS) MRI and MRS imaging services for small animals (mice, rats, gerbils) provided by the Environmental Magnetic Resonance Laboratory for Small Animals. Supports preclinical research studies for pharmaceutical and academic clients.
• Cytotoxicity Assessment on Human or Animal Cell Cultures Cytotoxicity evaluation services for compounds on human or animal cell cultures, provided by the Environmental Laboratory for Pharmacological and Toxicological Research (ŚLBFiT). Supports preclinical pharmacology and toxicology testing for external clients.
• Laboratory Animal Breeding and Housing Services Breeding, housing, and maintenance of selected mouse strains and research services using laboratory rodents under Specific Pathogen-Free (SPF) high-health-standard conditions, with genetic modification capabilities. Provided by the Environmental Laboratory for Genetically Modified Animals (LHZ).
• Electron Microscopy Imaging Electron microscopy imaging services for biomedical research applications, provided by the Environmental Microscopic-Electron Research Laboratory. Serves academic, biotech, and pharmaceutical clients requiring high-resolution structural analysis.
• IMDiK PAN Quality Mark (Znak Jakości) Certification Quality guarantee mark awarded to products and methods tested by the institute, including medical devices, pharmaceutical products, cosmetics, dietary supplements, and diagnostic methods. Serves Polish manufacturers seeking credible third-party validation.

Quantifiable outcome

• Category A+ achieved in medical sciences discipline, placing institute among top research institutions in Poland
• +3 more outcomes

Named customers4 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

14 partnerships are on record, tiered core and minor.

• BioImaging Poland (BIPol)coreStrategic or Co-development Partner · 2 July 2020Consortium registered on Polish Map of Research Infrastructure (decision DIR/PMIB/2020/143 dated 02.07.2020). Provides open access to biological and biomedical imaging infrastructure for researchers across Poland. Led by Instytut Biologii Doświadczalnej im. M. Nenckiego PAN.
• Biocentrum OchotacoreStrategic or Co-development PartnerConsortium of research institutions on Ochota campus in Warsaw, promoting interdisciplinary collaboration in biological and medical research.
• Centrum Zaawansowanych Technologii BIM (CZT BIM)coreStrategic or Co-development PartnerConsortium focusing on advanced technologies in biomedicine, biotechnology, and applied informatics, supporting translational research initiatives.
• Centrum Badań Przedklinicznych i Technologii (CEPT)coreStrategic or Co-development PartnerCollaborative center providing preclinical research services and advanced technologies for biomedical research, with shared facilities including MRI imaging and laser microscopy laboratories.
• Euro-BioImaging (EuBI)coreStrategic or Co-development PartnerPan-European research infrastructure for biological and biomedical imaging. The institute's Environmental Laser Microscopy Laboratory (LLTM) joined EuBI in December 2015 as one of 28 member facilities, enabling collaboration with research groups worldwide.
• Association of Polish NeuropathologistsminorStrategic or Co-development PartnerJoint publication of Folia Neuropathologica journal, indexed in Journal Citation Reports (JCR), promoting neuropathology research in Poland.
• Instytut Homeostazy Sp. z o.o.coreStrategic or Co-development PartnerJoint patent ownership for peptidomimetics for pancreatic cancer therapy and peptide preparations for glioblastoma treatment. Commercial partner for drug development research.
• GBJ PHARMA Sp. z o.o.minorStrategic or Co-development PartnerJoint patent application for latanoprost delivery systems for intraocular pressure reduction. Commercial partner for pharmaceutical development.
• Warsaw Medical University (WUM)coreStrategic or Co-development PartnerJoint research partner and co-patent owner for selenium nanoparticle conjugates for cancer treatment. Clinical research collaboration through clinical-research teams.
• University of Warsaw (UW)coreStrategic or Co-development PartnerJoint patent owner for selenium nanoparticle conjugates research. Collaboration in nanomedicine and cancer research.
• Medical University of Lublin (UM)minorStrategic or Co-development PartnerJoint patent owner for medical use of kynurenic acid in cardiac diseases. Collaboration in cardiovascular research.
• National Institute of Medicines (NIL)minorStrategic or Co-development PartnerJoint patent owner for selenium nanoparticle conjugates. Collaboration in pharmaceutical research.
• Doctoral School of Translational Medicine B2B4PhDcoreStrategic or Co-development PartnerJoint doctoral school with clinical translation focus, providing PhD training in translational medicine between bench and bedside.
• Doctoral School of Information and Biomedical Technologies TIB PANcoreStrategic or Co-development PartnerJoint doctoral school with information and biomedical technology focus, providing interdisciplinary PhD training across PAN institutes.

Scale indicators8 records

Recent moves11 records

Expansion highlights6 records

Broad incumbents

• Charles River Laboratories: Global contract research organization providing preclinical and clinical laboratory services to pharma and biotech. Comparable given IMDiK PAN's commercial preclinical service offerings (toxicology, animal models, imaging), though Charles River operates at vastly larger commercial scale.
• The Francis Crick Institute: Leading UK biomedical discovery institute conducting interdisciplinary research in cancer, neuroscience, and immunology. Comparable given broad biomedical research mandate, publication output scale, and translational research focus, though with substantially larger funding and headcount.
• Max Planck Institute for Molecular Biomedicine: Major German biomedical research institute with expertise in stem cell biology, vascular biology, and disease modeling. Comparable given similar iPSC/organoid research focus and tier-1 research institution status, though with significantly larger funding base.
• Charité - Universitätsmedizin Berlin: One of Europe's largest university hospitals and research institutions with strong translational medicine programs. Peer given integrated basic-to-clinical research model similar to IMDiK PAN's translational pipeline, though at much larger scale.

Regional players

• Łukasiewicz Research Network: Poland's largest applied research network with biomedical and pharmaceutical research institutes. Regional peer offering similar contract research and technology services to industry, though more applied and manufacturing-oriented than IMDiK PAN's basic research focus.

Direct peers

• Maria Skłodowska-Curie National Research Institute of Oncology: Poland's primary oncology research and treatment center, focused on cancer research, diagnostics, and treatment. Directly comparable given the institute's cancer research focus, including peptide therapeutics and preclinical oncology studies.
• International Institute of Molecular and Cell Biology (IIMCB): Warsaw-based biomedical research institute conducting molecular and cell biology research. Comparable as a Polish research institution with international collaborations, similar grant funding structure, and overlapping research themes in cell biology and disease modeling.
• Nencki Institute of Experimental Biology PAN: Fellow Polish Academy of Sciences institute in Warsaw focused on biological and biomedical research. Direct peer given shared PAN parent, complementary neuroscience and cell biology research, and joint participation in Biocentrum Ochota and BioImaging Poland consortia.
• Institute of Bioorganic Chemistry PAN: Polish Academy of Sciences institute specializing in bioorganic chemistry, nucleic acid chemistry, and chemical biology. Peer given shared PAN governance, similar research excellence focus, and complementary expertise in molecular biology and drug development.
• Medical University of Warsaw: Leading Polish medical university with extensive biomedical research programs. Direct peer and active collaborator (joint patent ownership, clinical-research teams) with comparable translational medicine focus and shared doctoral training programs.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat6 records

Key risks5 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/immdik

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Mossakowski Medical Research Institute